Treatment of membranous nephropathy with crescent nephritis by rituximab: A case report

被引：0

作者：

Zhang, Fan ^{[1
,2
]}

Yang, Yiya ^{[1
,2
]}

Chen, Yinyin ^{[1
,2
]}

Chen, Ying ^{[1
,2
]}

Yin, Wei ^{[1
,2
]}

Liang, Yumei ^{[1
,2
]}

Luo, Xun ^{[1
,2
]}

机构：

[1] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Nephrol, 61 West Jiefang Rd, Changsha 410000, Hunan, Peoples R China

[2] Hunan Normal Univ, Hunan Prov Peoples Hosp, Lab Kidney Dis, 61 West Jiefang Rd, Changsha 410000, Hunan, Peoples R China

来源：

MEDICINE | 2022年 / 101卷 / 37期

关键词：

antiphospholipaseA2 receptor antibodies; crescentic glomerulonephritis; membranous nephropathy; RECEPTOR; ANTIBODY; GLOMERULONEPHRITIS; ANTIGEN;

D O I：

10.1097/MD.0000000000030663

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Crescent formation is rare in primary membranous nephropathy (MN). The mechanism of crescent formation is unknown and the treatments are tentative. Patient concerns: A 71-year-old woman presented with nephrotic syndrome, hematuria, and rapidly progressive kidney dysfunction. Diagnosis: Kidney biopsy was performed, and the diagnosis was MN in combination with crescentic glomerulonephritis. Circulating anti-PLA2R was detected of a high level. Interventions: The patient received rituximab besides corticosteroids. Outcomes: The patient achieved complete remission of proteinuria and recovery of kidney function. Conclusion: Our case suggests that there is a pathologic feature of MN and crescents in the absence of known immunologic factors as well as rituximab could serve as an effective cure and could be considered in serious MN conditions.

引用

页数：3

共 50 条

[1] Treatment of Membranous Nephropathy With Crescent Nephritis by Rituximab With Corticosteroids
Zhang, Fan
Yang, Yiya
Chen, Yinyin
Liang, Yumei
Luo, Xun
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 802 - 802
[2] Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
Vissing-Uhre, Roald
Hansen, Alastair
Frevert, Susanne
Hansen, Ditte
CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2021, 11 (02): : 116 - 123
[3] THE USE OF RITUXIMAB IN MEMBRANOUS LUPUS NEPHRITIS: A CASE REPORT
Kaisar, M. O.
Peh, C. A.
Bannister, K. M.
NEPHROLOGY, 2007, 12 : A10 - A10
[4] Idiopathic membranous nephropathy preceding membranous lupus nephritis: a case report
Gokalp, C.
Aygun, G.
Dogan, A. F.
Usta, U.
Kurultak, I.
Ustundag, S.
LUPUS, 2020, 29 (03) : 340 - 343
[5] BucillamineAcute interstitial nephritis with membranous nephropathy: case report
Reactions Weekly, 2016, 1606 (1) : 39 - 39
[6] Treatment with rituximab in idiopathic membranous nephropathy
Fiorentino, Marco
Tondolo, Francesco
Bruno, Francesca
Infante, Barbara
Grandaliano, Giuseppe
Gesualdo, Loreto
Manno, Carlo
CLINICAL KIDNEY JOURNAL, 2016, 9 (06) : 788 - 793
[7] Rituximab treatment of idiopathic membranous nephropathy
Fervenza, F. C.
Cosio, F. G.
Erickson, S. B.
Specks, U.
Herzenberg, A. M.
Dillon, J. J.
Leung, N.
Cohen, I. M.
Wochos, D. N.
Bergstralh, E.
Hladunewich, M.
Cattran, D. C.
KIDNEY INTERNATIONAL, 2008, 73 (01) : 117 - 125
[8] Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Fervenza, F. C.
Appel, G. B.
Barbour, S. J.
Rovin, B. H.
Lafayette, R. A.
Aslam, N.
Jefferson, J. A.
Gipson, P. E.
Rizk, D. V.
Sedor, J. R.
Simon, J. F.
McCarthy, E. T.
Brenchley, P.
Sethi, S.
Avila-Casado, C.
Beanlands, H.
Lieske, J. C.
Philibert, D.
Li, T.
Thomas, L. F.
Green, D. F.
Juncos, L. A.
Beara-Lasic, L.
Blumenthal, S. S.
Sussman, A. N.
Erickson, S. B.
Hladunewich, M.
Canetta, P. A.
Hebert, L. A.
Leung, N.
Radhakrishnan, J.
Reich, H. N.
Parikh, S. V.
Gipson, D. S.
Lee, D. K.
da Costa, B. R.
Juni, P.
Cattran, D. C.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 36 - 46
[9] Treatment of lupus nephritis with rituximab: a case report
Pinto, H.
Brito, I.
Afonso, C.
PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1651 - 1651
[10] A case of mixed membranous nephropathy and purpura nephritis
Ehara, T
Muramatsu, T
Shigematsu, H
CLINICAL NEPHROLOGY, 2002, 57 (06) : 480 - 483

← 1 2 3 4 5 →